Hydroxyurea (HU) blocks DNA synthesis by inhibitoion of the cellular enzyme ribonucleotide reductase. It has been…
Author: Tom
A phase 3, open-label, follow-up study to protocol HIV-NAT 002.1 to explore the durability of the antiretroviral efficacy and durability of ddI/d4T and AZT/3TC in a population originally treated with ddI/d4T, and explore the efficacy of adding hydroxyurea to failing therapy with two nucleosides
To determine durability of the virological and immunological responses of participants on study 002.1 who were…
A study of the safety, tolerance and pharmacokinetics of Nelfinavir co-administered with Stavudine (d4T) and Didanosine (ddI) in HIV-exposed infants
The pediatric oral powder formulation of Nelfinavir has been studied in small groups of HIV-infected children
Publications 1997
Ruxrungtham K. Highlights from the fourth international conference on AIDS in Asia and the pacific. HIV…